Skip to main content
SpringerLink
Log in

Invited Commentary

Hepatorenal syndrome — Pathogenesis and Treatment

  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References and Recommended Reading

  1. Arroyo V, Ginés P, Gerbes A, et al.: Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996, 23:164–176.

    Article  PubMed  CAS  Google Scholar 

  2. Schrier RW, Arroyo V, Bernardi M, et al.: Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988, 8:1151–1157.

    Article  PubMed  CAS  Google Scholar 

  3. Cárdenas A, Uriz J, Arroyo V: Hepatorenal syndrome. Liver Transplantation 2000, 4(suppl 1):S63-S71.

    Google Scholar 

  4. Martin PY, Gines P, Schrier RW: Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N Engl J Med 1998, 339:533–541.

    Article  PubMed  CAS  Google Scholar 

  5. Ginés A, Escorsell A, Ginés P, et al.: Incidence, predictive factors, and prognosis of hepatorenal syndrome in cirrhosis. Gastroenterology 1993, 105:229–236.

    PubMed  Google Scholar 

  6. Sort P, Navasa M, Arroyo V, et al.: Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999, 5:403–409.

    Article  Google Scholar 

  7. Akriviadis E, Botla R, Briggs W, et al.: Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology 2000, 119:1637–1648.

    Article  PubMed  CAS  Google Scholar 

  8. Guevara M, Ginés P, Fernández-Esparrach G, et al.: Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion. Hepatology 1998, 27:35–41.

    Article  PubMed  CAS  Google Scholar 

  9. Uriz J, Ginés P, Cárdenas A, et al.: Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome. J Hepatol 2000, 33:43–48.

    Article  PubMed  CAS  Google Scholar 

  10. Angeli P, Volpin R, Gerunda G, et al.: Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology 1999, 29:1690–1697.

    Article  PubMed  CAS  Google Scholar 

  11. Brensing KA, Textor J, Perz J, et al.: Long term outcome after transjugular intrahepatic portosystemic stent-shunt in nontransplant cirrhotics with hepatorenal syndrome: a phase II study. Gut 2000, 47:288–295.

    Article  PubMed  CAS  Google Scholar 

  12. Rimola A, Navasa M, Grande L: Liver transplantation in cirrhotic patients with ascites. In Ascites and Renal Dysfunction in Liver Disease: Pathogenesis, Diagnosis, and Treatment. Edited by Arroyo V, Ginés P, Rodés J, Schrier RW. Malden: Blackwell Science; 1999:522–537.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Liver Unit, Institut de Malalties Digestives Hospital Clínic, Villarroel 170, 08036, Barcelona, Spain

    Andres Cárdenas MD & Vicente Arroyo MD

Authors
  1. Andres Cárdenas MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vicente Arroyo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cárdenas, A., Arroyo, V. Invited Commentary. Curr Gastroenterol Rep 4, 1–4 (2002). https://doi.org/10.1007/s11894-002-0029-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-002-0029-8

Keywords

Search

Navigation